Treatment Approaches for Diffuse Cutaneous Mastocytosis in Children: Literature Review and Actual Clinical Experience

Background. Mastocytosis is a very rare disease with various manifestations, based on abnormal clonal proliferation of mast cells in organs and tissues, such as: skin, bone marrow, lymph nodes, liver, spleen, and gastrointestinal tract. The diagnosis can be established according to clinical manifestations, laboratory, and instrumental data. Darier’s sign and histological examination are crucial for mastocytosis diagnosis. The presented clinical case describes very rare cutaneous form of mastocytosis. Clinical case description. The girl, 2.5 years old, was hospitalized with multiple erythematous papules on her body, face, and limbs. Comprehensive examination, including bone marrow biopsy and positron-emission tomography, allowed us to exclude mastocytosis systemic manifestations. Conclusion. Despite the fact that mastocytosis in children is mostly represented by skin form, it is necessary to perform complex patient examination on any systemic damage. Antihistamines in combination with topical and/or systemic glucocorticoids are often effective, but complete response does not always occur. Implementation of other therapeutic options, such as targeted drugs (tyrosine kinase inhibitors), is suggested In case of no or insufficient therapeutic effect.

1. Cohen SS, Skovbo S, Vestergaard H, et al. Epidemiology of systemic mastocytosis in Denmark. Br J Haematol. 2014;166(4): 521–528. doi: https://doi.org/10.1111/bjh.12916

2. Khoury JD, Solary E, Abla O, et al. The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703–1719. doi: https://doi.org/10.1038/s41375-022-01613-1

3. Lee HJ, Jang MJ, Bae EY, et al. Bullous cutaneous mastocytosis, a rarely reported disease in Asian children. Asian Pac J Allergy Immunol. 2014;32(4):354–357. doi: https://doi.org/10.12932/AP0471.32.4.2014

4. Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 update WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420–1427. doi: https://doi.org/10.1182/blood-2016-09-731893

5. Koga H, Kokubo T, Akaishi M, et al. Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature. Pediatr Dermatol. 2011;28(5):542–546. doi: https://doi.org/10.1111/j.1525-1470.2010.01212.x

6. Klaiber N, Kumar S, Irani AM. Mastocytosis in Children. Curr Allergy Asthma Reports. 2017;17(11):80. doi: https://doi.org/10.1007/s11882-017-0748-4

7. Melikyan AL, Subortseva IN, Shuvaev VA, et al. National clinical recommendations for the diagnosis and treatment of mastocytosis. Russian Journal of Hematology and Transfusiology. 2021;66(2):280–311. (In Russ). doi: https://doi.org/10.35754/0234- 5730-2021-66-2-280-311

8. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi: https://doi.org/10.1182/blood-2016-03-643544

9. Schaffer JV. Pediatric Mastocytosis: Recognition and Management. Am J Clin Dermatol. 2021;22(2):205–220. doi: https://doi.org/10.1007/s40257-020-00581-5

10. Meni C, Bruneau J, Gerogin-Lavialle S, et al. Pediatric mastocytosis: A systematic review of 1747 cases. Dr J Dermatolog. 2015;172(3):642–651. doi: https://doi.org/10.1111/bjd.13567

11. Hartmann K, Escribano L, Grattan C, et al. Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol. 2016;137(1):35–45. doi: https://doi.org/10.1016/j.jaci.2015.08.034

12. Matito A, Azaña JM, Torrelo A, Alvarez-Twose I. Cutaneous Mastocytosis in Adults and Children New Classification and Prognostic Factors. Immunol Allergy Clin North Am. 2018;38(3): 351–363. doi: https://doi.org/10.1016/j.iac.2018.04.001

13. Hannaford R, Rogers M. Presentation of cutaneous mastocytosis in 173 children. Australas J Dermatol. 2001;42(1):15–21. doi: https://doi.org/10.1046/j.1440-0960.2001.00466.x

14. Hosking AM, Makdisi J, Ortenzio F, et al. Diffuse cutaneous mastocytosis: Case report and literature review. Pediatr Dermatol. 2018;35(6):348–352. doi: https://doi.org/10.1111/pde.13651

15. Pardanani A. Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2016; 91(11):1146–1159. doi: https://doi.org/10.1002/ajh.24553

16. Azan JM, Torrelo A, Matito A. Update on mastocytosis (part 2): Categories, Prognosis, and Treatment. Actas Dermosifiliogr. 2016;107(1):15–22. doi: https://doi.org/10.1016/j.adengl.2015.11.002

17. Mashiah J, Harel A, Bodemer C, et al. Topical pimecrolimus for pediatric cutaneous mastocytosis. Clin Exp Dermatol. 2018;43(5):559–565. doi: https://doi.org/10.1111/ced.1339

18. Matito A, Blázquez-Goñi C, Morgado JM, et al. Shortterm omalizumab treatment in an adolescent with cutaneous mastocytosis. Ann Allergy Asthma Immunol. 2013;111(5):425–426. doi: https://doi.org/10.1016/j.anai.2013.08.014

19. Liu M, Kohn L, Roach G, et al. Treatment of systemic mastocytosis in an infant with midostaurin. J Allergy Clin Immunol Pract. 2019;7(8):2929–2931. doi: https://doi.org/10.1016/j.jaip.2019.05.032

20. Hoffmann KM, Moser A, Lohse P, et al. Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-yearold boy carrying a somatic KIT mutation. Blood. 2008;112(5): 1655–1657. doi: https://doi.org/10.1182/blood-2008-03-147785

21. Lange M, Hartmann K, Carter MC, et al. Molecular background, clinical features and management of pediatric mastocytosis: status 2021. Int J Mol Sci. 2021;22(5):2586. doi: https://doi.org/10.3390/ijms22052586

22. Akin C. Mast cell activation syndromes. J Allergy Clin Immunol. 2017;140(2):349–355. doi: https://doi.org/10.1016/j.jaci. 2017.06.007

23. Kambe N, Longley BJ, Miyachi Y, Kabashima K. KIT Masters Mast Cells in Kids, Too. J Invest Dermatol. 2010;130(3):648–650. doi: https://doi.org/10.1038/jid.2009.291

24. Bodemer C, Hermine O, Palmerini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol. 2010;130(3):804–815. doi: https://doi.org/10.1038/jid.2009.281

25. Castells M, Butterfield J. Mast cell activation syndrome and mastocytosis: Initial treatment options and long-term management. J Allergy Clin Immunol Pract. 2019;7(4):1097–1106. doi: https://doi.org/10.1016/j.jaip.2019.02.002

26. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185–1196. doi: https://doi.org/10.1093/ajcn/85.5.1185

27. Carter MC, Metcalfe DD, Matito A, et al. Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: a group report of the Mast Cells Disorder Committee, American Academy of Allergy and Immunology. J Allergy Clin Immunol. 2019;143(3): 880–893. doi: https://doi.org/10.1016/j.jaci.2018.10.063

28. Bankova LG, Walter JE, Iyengar SR, et al. Castells. Generalized Bullous Eruption after Routine Vaccination in a Child with Diffuse Cutaneous Mastocytosis. J Allergy Clin Immunol Pract. 2013;1(1): 94–96. doi: 10. https://doi.org/1016/j.jaip.2012.08.008 2

29. Hermans MAW, Arends NJT, Gerth van Wijk R, et al. Management around invasive procedures in mas-tocytosis: an update. Ann Allergy Asthma Immunol. 2017;119(4):304–309. doi: https://doi.org/10.1016/j.anai.2017.07.022

30. Broesby-Olsen S, Dybedal I, Gulen T, et al. Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus. Acta Derm Venereol. 2016;96(5):602–612. doi: https://doi.org/10.2340/00015555-2325

31. Morren MA, Hoppé A, Renard M, et al. Imatinib mesylate in the treatment of diffuse cutaneous mastocytosis. J Pediatr. 2013;162(1):205–207. doi: https://doi.org/10.1016/j.jpeds.2012.08.035

32. Sciumè M, De Magistris C, Galli N, et al. Target Therapies for Systemic Mastocytosis: An Update. Pharmaceuticals (Basel). 2022;15(6):738. doi: https://doi.org/10.3390/ph15060738